Vivo Capital, LLC Legend Biotech Corp Transaction History

Vivo Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$41.14 - $56.98 $10.1 Million - $13.9 Million	-244,376 Reduced 50.0%	244,375 $11.4 Million
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $16.5 Million - $23.7 Million	-467,951 Reduced 48.91%	488,751 $24.7 Million
Q2 2021 Aug 16, 2021	SELL	$25.8 - $41.09 $46.4 Million - $73.9 Million	-1,798,305 Reduced 65.27%	956,702 $39.3 Million
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $14.8 Million - $18.6 Million	-575,262 Reduced 17.27%	2,755,007 $77.6 Million
Q3 2020 Nov 13, 2020	SELL	$27.5 - $39.61 $6.18 Million - $8.9 Million	-224,738 Reduced 6.32%	3,330,269 $103 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $128 Million - $151 Million	3,555,007 New	3,555,007 $151 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.